Gene · 963
Papers1,502
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,502
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Regulation of Exosome Generation and Function in Physiological and Pathological Processes. | Int J Mol Sci | 2023 | 38203424 | PubTator, text mining | PubMed |
| Editorial: Mechanism and therapeutic potential of macrophages in metabolic and cardiovascular diseases. | Front Immunol | 2023 | 38173724 | PubTator, text mining | PubMed |
Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma. | Front Immunol | 2023 | 38162649 | PubTator, text mining | PubMed |
| Knockouts of TNFRSF1A and TNFRSF1B Genes in K562 Cell Line Lead to Diverse Long-Lasting Responses to TNF-α. | Int J Mol Sci | 2023 | 38138998 | PubTator, text mining | PubMed |
| Identification of driver genes in lupus nephritis based on comprehensive bioinformatics and machine learning. | Front Immunol | 2023 | 38130724 | PubTator, text mining | PubMed |
| Single-cell landscape of immune cells during the progression from HBV infection to HBV cirrhosis and HBV-associated hepatocellular carcinoma. | Front Immunol | 2023 | 38116005 | PubTator, text mining | PubMed |
| Suppression of NK Cell Activation by JAK3 Inhibition: Implication in the Treatment of Autoimmune Diseases. | J Immunol Res | 2023 | 38106519 | PubTator, text mining | PubMed |
| Recurring EPHB1 mutations in human cancers alter receptor signalling and compartmentalisation of colorectal cancer cells. | Cell Commun Signal | 2023 | 38102712 | PubTator, text mining | PubMed |
| How to know when little kidneys are in trouble: a review of current tools for diagnosing AKI in neonates. | Front Pediatr | 2023 | 38078317 | PubTator, text mining | PubMed |
| Clinical practice and outcomes of preimplantation genetic testing for CMT1A using a novel direct detection method. | Heliyon | 2023 | 38045147 | PubTator, text mining | PubMed |
| Trehalose-Bearing Carriers to Target Impaired Autophagy and Protein Aggregation Diseases. | J Med Chem | 2023 | 38031413 | PubTator, text mining | PubMed |
| Extracellular vesicles modulate key signalling pathways in refractory wound healing. | Burns Trauma | 2023 | 38026441 | PubTator, text mining | PubMed |
| Selection, characterization and in vivo evaluation of novel CD44v6-targeting antibodies for targeted molecular radiotherapy. | Sci Rep | 2023 | 38001360 | PubTator, text mining | PubMed |
| Integrative single-cell RNA-seq analysis of vascularized cerebral organoids. | BMC Biol | 2023 | 37940920 | PubTator, text mining | PubMed |
| Gene purging and the evolution of Neoave metabolism and longevity. | J Biol Chem | 2023 | 37918802 | PubTator, text mining | PubMed |
Single-cell mass cytometric analysis of peripheral immunity and multiplex plasma marker profiling of non-small cell lung cancer patients receiving PD-1 targeting immune checkpoint inhibitors in comparison with platinum-based chemotherapy. | Front Immunol | 2023 | 37901220 | PubTator, text mining | PubMed |
| Extracellular Vesicles as a Translational Approach for the Treatment of COVID-19 Disease: An Updated Overview. | Viruses | 2023 | 37896755 | PubTator, text mining | PubMed |
| Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4. | Int J Mol Sci | 2023 | 37894816 | PubTator, text mining | PubMed |
| TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors. | Biomedicines | 2023 | 37893178 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis reveals the key genes associated with macrophage polarization in liver cancer. | Hepatol Commun | 2023 | 37889536 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/963/papers?page=4